CH201760A - Process for the preparation of k-strophanthin-B. - Google Patents
Process for the preparation of k-strophanthin-B.Info
- Publication number
- CH201760A CH201760A CH201760DA CH201760A CH 201760 A CH201760 A CH 201760A CH 201760D A CH201760D A CH 201760DA CH 201760 A CH201760 A CH 201760A
- Authority
- CH
- Switzerland
- Prior art keywords
- strophanthin
- alcohol
- chloroform
- water
- solution
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- FHIREUBIEIPPMC-UHFFFAOYSA-N K-Strophanthin-beta Natural products O1C(C)C(OC2C(C(O)C(O)C(CO)O2)O)C(OC)CC1OC(CC1(O)CCC2C3(O)CC4)CCC1(C=O)C2CCC3(C)C4C1=CC(=O)OC1 FHIREUBIEIPPMC-UHFFFAOYSA-N 0.000 title 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- CTNPHHZPAJYPFO-QFLJTSPFSA-N k-Strophanthoside Chemical compound C1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C=O)CC[C@@H](C[C@@]5(O)CC[C@H]4[C@@]3(O)CC2)O[C@H]2C[C@@H]([C@@H]([C@@H](C)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)OC)=CC(=O)OC1 CTNPHHZPAJYPFO-QFLJTSPFSA-N 0.000 claims description 4
- GILGYKHFZXQALF-UHFFFAOYSA-N k-Strophantylside Natural products O1C(C)C(OC2C(C(O)C(O)C(COC3C(C(O)C(O)C(CO)O3)O)O2)O)C(OC)CC1OC(CC1(O)CCC2C3(O)CC4)CCC1(C=O)C2CCC3(C)C4C1=CC(=O)OC1 GILGYKHFZXQALF-UHFFFAOYSA-N 0.000 claims description 4
- 102100024295 Maltase-glucoamylase Human genes 0.000 claims description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 229930182478 glucoside Natural products 0.000 description 6
- 150000008131 glucosides Chemical class 0.000 description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000511943 Strophanthus Species 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- GOYBREOSJSERKM-DSYKOEDSSA-N D-cymarose Chemical compound O=CC[C@H](OC)[C@H](O)[C@@H](C)O GOYBREOSJSERKM-DSYKOEDSSA-N 0.000 description 3
- GOYBREOSJSERKM-UHFFFAOYSA-N D-oleandrose Natural products O=CCC(OC)C(O)C(C)O GOYBREOSJSERKM-UHFFFAOYSA-N 0.000 description 3
- ZNDMLUUNNNHNKC-UHFFFAOYSA-N G-strophanthidin Natural products CC12CCC(C3(CCC(O)CC3(O)CC3)CO)C3C1(O)CCC2C1=CC(=O)OC1 ZNDMLUUNNNHNKC-UHFFFAOYSA-N 0.000 description 3
- ODJLBQGVINUMMR-UHFFFAOYSA-N Strophanthidin Natural products CC12CCC(C3(CCC(O)CC3(O)CC3)C=O)C3C1(O)CCC2C1=CC(=O)OC1 ODJLBQGVINUMMR-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- ODJLBQGVINUMMR-HZXDTFASSA-N strophanthidin Chemical compound C1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@@]5(O)CC4)C=O)CC[C@@]32C)=CC(=O)OC1 ODJLBQGVINUMMR-HZXDTFASSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229910021514 lead(II) hydroxide Inorganic materials 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- XQCGNURMLWFQJR-ZNDDOCHDSA-N Cymarin Chemical compound O1[C@H](C)[C@@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)CC[C@@H]3[C@@]2(C=O)CC1 XQCGNURMLWFQJR-ZNDDOCHDSA-N 0.000 description 1
- XQCGNURMLWFQJR-UESCRGIISA-N Cymarin Natural products O=C[C@@]12[C@@](O)(C[C@@H](O[C@H]3O[C@@H](C)[C@@H](O)[C@@H](OC)C3)CC1)CC[C@H]1[C@]3(O)[C@@](C)([C@H](C4=CC(=O)OC4)CC3)CC[C@H]21 XQCGNURMLWFQJR-UESCRGIISA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000002036 chloroform fraction Substances 0.000 description 1
- 229960003083 cymarin Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung von k-Strophanthin-p- Es ist bekannt, dass in den Samen von Strophanthus kombö rieben den seit längerer Zeit in reiner Form hergestellten kristalli sierten, Glucosiden Cymarin (Strophanthidin + Cymarose) und k-Strophatithin-p (Stro- phanthidin <B>+</B> Cymarose <B>+ 1</B> Mol Glucose) noch andere herzaktive Glucoside vorkommen,
welche mehrere Moleküle Glucose enthalten (vergl. die zusammenfassende Abhandlung von W.<B>A.</B> Jacobs, Physiologieal Reviews<B>13,</B> <B>S.</B> 22 [1933]).
Es wurde nun gefunden, dass man das k-Strophanthin-p herstellen kann, dadurch dass man a-Glucosidase auf das k-Strophan- thosid einwirken lässt. Das k-Strophanthosid besteht aus Strophanthidin, Cymarose und 2 Mol Glucose und kann zum Beispiel nach dem in der Patentschrift Nr. <B>199908</B> beschrie benen Verfahren in reiner Form gewonnen werden.
Zur Ausführung des vorliegenden Verfahrens kann man vom reinen, kristalli sierten k-Sti-ophanthosid ausgehen oder rohe Glucosidgemische, wie sie durch Extraktion von Strophanthus-komb6-Sameii dargestellt werden, verwenden. Bei der Ausführung des erfindungsgemässen Verfahr-ens wei-den zweck mässig Temperatur und pH-Wert dein vei, wendeten Eiizymmaterial angepasst.
Das neue Verfahren ermöglicht-, aus Stro- phanthus komb6-Samen das k-Strophanthin-p in einer Ausbeute zu gewinnen, die das mehr fache der bisherigen beträgt. Dementent- spi-echend wird nach dieser Arbeitsweise die Hauptmenge der vorhandenen herzaktiven Glucoside in der Form des k-Strophanthin-p gewonnen, welches in der-Therapie Verwen dung finden soll.
<I>Beispiel<B>1:</B></I> <B><I>1</I> g</B> reines kristallisiertes k-Stropbaritho- sid (vergl. Patent Nr. <B>199908)</B> wird in<B>30</B> cm' Wasser gelöst, mit<B>10</B> cm8 Hefelösung und <B>10</B> cm3 '/8 molar-Phosphatpuffer von pE <B>= 6,8</B> versetzt und das Gemisch in Thermostaten bei<B>30 '</B> gehalten.
Die Hefelösung wurde durch Neutral-Autolyse von gewöhnlicher Brauereihefe gewonnen,<B>10</B> cm8 derselben entsprechen<B>1 g</B> Hefetrockensubstanz und vermögen eine 5/oige Maltose16sung in <B>135</B> Minuten zu 50'/o zu spalten. Nach<B>65</B> Stun den wird der Ansatz dreimal mit solchen Mengen Chloroform-Alkohol ausgeschüttelt, dass das Verhältnis Wasser: Chloroform<B>- Al-</B> kohol<B>=</B> 2<B>:</B> 2:<B>1</B> ist.
Die Chloroform-Frak- tionen werden zur Trockene eingedampft und der Rückstand mit wenig Wasser angerieben. Sofort kristallisieren 0,4<B>g</B> reines k-Strophan- thin-p aus. Es wurden also 50'/o des glucose- reicheren Glucosids in dieser Zeit in k-Stro- phanthin-p übergeführt.
<I>Beispiel 2:</I> 2<B>g</B> rohes, nicht kristallisiertes k-Stro- phanthosid, welches, wie im Patent Nr. <B>199908</B> angegeben, durch Extraktion der entfetteten Samen von Strophantus kombd mit Ohloro- form-Alkohol oder wässerigem Alkohol und darauffolgender Abtrennung der Gerbstoffe mit Bleihydroxyd und Fraktionierung der Glucoside mit Chloroform-Alkohol-Wasser oder Alkohol und Äther dargestellt wurde,
werden mit<B>30</B> eins Hefelösung entspreehend Beispiel<B>1</B> bei pH # <B>6,8</B> behandelt und wie dort angegeben, weiter verarbeitet. In diesem Falle können<B>1,1 g</B> k-Stropharithiii-# isoliert werden.
<I>Beispiel<B>3:</B></I> <B>1 kg</B> Strophanthus komb6-Sameii w,erden mit Chloroform-Alkohol oder wässerigem<B>Al-</B> kohol extrahiert und der eingedampfte Ex trakt erschöpfend mit Äther behandelt. Nach Abtrennung der Gerbstoffe mit Bleihydroxyd wird das rohe Orlucosidgemisch in 2 Liter Wasser aufgenommen und mit<B>600</B> eni3 eitier liefelösung aus<B>60 g</B> liefe (Trockengewicht) entsprechend Beispiel<B>1</B> bei pH == <B>6,8</B> behan delt.
Nach 120 Stunden wird die trübe Lö sung durch Talk geklärt und das Filtrat nach Zusatz von gesättigter Kochsalzlösung mit Chloroform zur Entfernung des Cymariiis sowie von gelbgefärbten schmierigen Verun reinigungen ausgeschüttelt. Die klare gelb gefärbte wässerige Lösung wird mit dem halben Volumen Alkohol versetzt und durch Ausschütteln mit Chloroform das k-Strophan- thin-p ausgezogen.
Die Behandlung mit Chlo- roform-Alkohol wird an der wässerigen Lö sung noch zweimal wiederholt, und zwar jedes- mal so, dass das Verhältnis Wasser: Chloro form<B>:</B> Alkohol == 2 :2<B>: 1</B> beträgt. Die abge trennten Chloroformlösungen werden im Va kuum eingeengt. Aus dem Rü-.kstand kri stallisiert sieh das k-Strophaiithin-p nach dem Anreiben mit wenig Wasser sofort aus. Die Ausbeute an rohem k-Strophanthin-A be trägt aus<B>1 kg</B> Droge bis<B>25</B> Lind mehr Gramm.
Das k-Strophanthin-p kann durch Umkristalli- sieren aus Alkohol-Wasser oder heissem Wasser rein erhalten werden.
Process for the production of k-strophanthin-p- It is known that in the seeds of Strophanthus kombö the crystallized glucosides cymarin (strophanthidin + cymarose) and k-strophantithin-p (strophanthidin, which have been produced in pure form for a long time) rubbed <B> + </B> Cymarose <B> + 1 </B> Mol glucose) there are other cardiac active glucosides,
which contain several molecules of glucose (cf. the comprehensive paper by W. <B> A. </B> Jacobs, Physiologieal Reviews <B> 13, </B> <B> S. </B> 22 [1933]) .
It has now been found that k-strophanthin-p can be produced by allowing α-glucosidase to act on k-strophanthin-p. The k-strophanthoside consists of strophanthidin, cymarose and 2 moles of glucose and can be obtained in pure form, for example, according to the process described in patent specification no. 199908 </B>.
To carry out the present process, one can start from the pure, crystallized k-sti-ophanthoside or use crude glucoside mixtures, such as those produced by extraction of Strophanthus komb6 Sameii. When the method according to the invention is carried out, the temperature and pH value of the egg enzyme material used are appropriately adapted.
The new process enables the k-strophanthin-p to be obtained from Strophanthus komb6 seeds in a yield which is several times that of the previous one. Correspondingly, according to this procedure, the main amount of the cardiac active glucosides present is obtained in the form of k-strophanthin-p, which is to be used in therapy.
<I>Example<B>1:</B> </I> <B> <I> 1 </I> g </B> pure crystallized k-stropbarithoside (see patent no. <B> 199908 ) </B> is dissolved in <B> 30 </B> cm 'water with <B> 10 </B> cm8 yeast solution and <B> 10 </B> cm3' / 8 molar phosphate buffer from pE < B> = 6.8 </B> and the mixture kept in thermostats at <B> 30 '</B>.
The yeast solution was obtained by neutral autolysis of common brewer's yeast, <B> 10 </B> cm8 of this corresponds to <B> 1 g </B> dry yeast substance and is capable of a 5% maltose solution in <B> 135 </B> minutes split to 50 '/ o. After <B> 65 </B> hours, the batch is shaken out three times with such amounts of chloroform-alcohol that the ratio of water: chloroform <B> - Al- </B> alcohol <B> = </B> 2 < B>: <B> 2: <B> 1 </B>.
The chloroform fractions are evaporated to dryness and the residue is rubbed with a little water. Immediately 0.4 g of pure k-strophanthine-p crystallized out. Thus 50% of the glucose-rich glucoside was converted into k-strophanthin-p during this time.
<I> Example 2: </I> 2 <B> g </B> crude, non-crystallized k-strophanthoside, which, as stated in patent no. <B> 199908 </B>, is obtained by extraction of the defatted Strophantus seeds combined with Ohloroform alcohol or aqueous alcohol and the subsequent separation of the tannins with lead hydroxide and fractionation of the glucosides with chloroform-alcohol-water or alcohol and ether
are treated with <B> 30 </B> one yeast solution according to example <B> 1 </B> at pH # <B> 6.8 </B> and processed further as indicated there. In this case <B> 1.1 g </B> k-stropharithiii- # can be isolated.
<I> Example<B>3:</B> </I> <B> 1 kg </B> Strophanthus komb6-Sameii w, earth extracted with chloroform alcohol or aqueous <B> Al </B> alcohol and the evaporated extract is exhaustively treated with ether. After separating the tannins with lead hydroxide, the crude orlucoside mixture is taken up in 2 liters of water and poured with <B> 600 </B> eni3 feed solution from <B> 60 g </B> (dry weight) according to example <B> 1 </ B> treated at pH == <B> 6.8 </B>.
After 120 hours the cloudy solution is clarified with talc and the filtrate is shaken out after adding saturated sodium chloride solution with chloroform to remove the cymariis and yellow-colored greasy impurities. Half the volume of alcohol is added to the clear, yellow-colored aqueous solution and the k-strophantine-p is extracted by shaking it out with chloroform.
The treatment with chloroform alcohol is repeated twice more on the aqueous solution, each time so that the ratio of water: chloroform <B>: </B> alcohol == 2: 2 <B>: 1 </B>. The separated chloroform solutions are concentrated in vacuo. The k-strophaiithin-p looks crystallized from the residue after rubbing with a little water. The yield of raw k-strophanthin-A amounts to <B> 1 kg </B> drug to <B> 25 </B> and more grams.
The k-strophanthin-p can be obtained in pure form by recrystallization from alcohol-water or hot water.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH201760T | 1937-04-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH201760A true CH201760A (en) | 1938-12-15 |
Family
ID=4442931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH201760D CH201760A (en) | 1937-04-21 | 1937-04-21 | Process for the preparation of k-strophanthin-B. |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH201760A (en) |
-
1937
- 1937-04-21 CH CH201760D patent/CH201760A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH201760A (en) | Process for the preparation of k-strophanthin-B. | |
| DE638804C (en) | Process for the preparation of pure monoacetylresorcinol | |
| DE737540C (en) | Process for the production of k-strophantine-ª ‰ | |
| DE876441C (en) | Process for the production of a knitted body from hawthorn | |
| AT202712B (en) | Process for the extraction of alkaloids | |
| DE706578C (en) | Process for obtaining preparations containing the circulatory hormone kallikrein | |
| DE414129C (en) | Process for the production of digitalis glucosides | |
| AT155175B (en) | Process for the production of enzymes from the nuclei of Prunus Armeniaca. | |
| AT122298B (en) | Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion. | |
| US2129285A (en) | Manufacture of k-strophanthine-beta | |
| DE588046C (en) | Method for the separation of the oestrus hormone from urine | |
| DE646651C (en) | Process for the production of a highly effective extract from senna leaves | |
| AT110560B (en) | Method for the preparation of a glycoside from Adonis vernalis L. | |
| DE579820C (en) | Process for obtaining female sex hormones in crystallized form | |
| DE1593183A1 (en) | Process for the production of saponins and sapogenins | |
| AT124421B (en) | Process for obtaining physiologically active extracts. | |
| AT112127B (en) | Process for the preparation of halogenated pyridine derivatives. | |
| DE868331C (en) | Process for the production of a bath additive containing humic acid | |
| AT132187B (en) | Process for the preparation of a crystallized digitalis glucoside. | |
| DE573314C (en) | Process for the production of iodine-protein-sugar-ferment compounds | |
| AT224807B (en) | Method for obtaining a new anti-tumor polysaccharide | |
| DE859514C (en) | Process for the extraction of anti-anemic substances from the liver | |
| DE461004C (en) | Process for the production of aqueous lipoid solutions | |
| DE480410C (en) | Method for the preparation of a glucoside from Adonis vernalis L. | |
| DE431512C (en) | Process for obtaining alkaloid preparations from drugs containing alkaloid, in particular from ergot |